Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Filter
  • 1-10 ل  65 نتائج ل ""differentiated thyroid carcinoma""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A phase I study of pazopanib in combination with escalating doses of 131I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine.

  • Authors : Chow LQ; Department of Medicine, Division of Medical Oncology, University of Washington, Fred Hutchison Cancer Research Center, Seattle, WA, United States of America.; Santana-Davila R

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Iodine Radioisotopes/Iodine Radioisotopes/Iodine Radioisotopes/*administration & dosage ; Pyrimidines/Pyrimidines/Pyrimidines/*therapeutic use

  • Source: PloS one [PLoS One] 2017 Jun 29; Vol. 12 (6), pp. e0178325. Date of Electronic Publication: 2017 Jun 29 (Print Publication: 2017).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

تفاصيل العنوان

×
  • 1-10 ل  65 نتائج ل ""differentiated thyroid carcinoma""